Michel Vounatsos
Director/Board Member bij REVVITY, INC.
Vermogen: 16 M $ op 29-02-2024
Profiel
Michel Vounatsos is lid van de raad van bestuur van PerkinElmer, Inc. (Verenigde Staten), LInstitut de RYthmologie et Modlisation Cardiaque en n-Lorem Foundation en Chief Executive Officer & Director bij Biogen, Inc. In zijn vorige carrière bekleedde hij de functie van President-Primary Care & Customer Business Line bij Merck & Co, Inc. De heer Vounatsos behaalde een MBA aan de cole des Hautes tudes Commerciales de Paris.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
BIOGEN INC.
0.05% | 28-04-2023 | 67 262 ( 0.05% ) | 15 M $ | 29-02-2024 |
REVVITY, INC.
0.01% | 15-05-2023 | 6 486 ( 0.01% ) | 710 801 $ | 29-02-2024 |
ZAI LAB LTD.
0.02% | 30-06-2023 | 183 320 ( 0.02% ) | 399 011 $ | 29-02-2024 |
Actieve functies van Michel Vounatsos
Bedrijven | Functie | Begin |
---|---|---|
REVVITY, INC. | Director/Board Member | 01-03-2020 |
ZAI LAB LIMITED | Director/Board Member | 07-01-2023 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Chief Executive Officer | 06-01-2017 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Chief Executive Officer | - |
L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | - |
n-Lorem Foundation | Director/Board Member | - |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Director/Board Member | - |
Eerdere bekende functies van Michel Vounatsos
Bedrijven | Functie | Einde |
---|---|---|
BIOGEN INC. | Chief Executive Officer | 14-11-2022 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-04-2016 |
Opleiding van Michel Vounatsos
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
BIOGEN INC. | Health Technology |
REVVITY, INC. | Health Technology |
ZAI LAB LIMITED | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Health Technology |
L’Institut de RYthmologie et Modélisation Cardiaque | |
n-Lorem Foundation | |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Health Technology |